The gradual dose titration for both is designed to minimise gastrointestinal effects

Follow the FDA-approved Instructions for Use (IFU) carefully: Rotate injection sites systematically (abdomen, thigh, or upper arm) Note that upper arm injections should be administered by a caregiver Avoid injecting into areas that are tender, bruised, red, hard, or have visible skin changes, scars, or moles [1] Follow the IFU regarding storage and preparation of the pen Clean the injection site with alcohol and allow it to dry completely Use a smooth, steady injection technique as instructed Do not inject into the same spot within at least one inch of a previous injection Managing Minor Injection Site Reactions can often be accomplished with simple measures: Apply a cool compress to reduce swelling and discomfort Avoid scratching or rubbing the affected area For mild itching, over-the-counter hydrocortisone cream may help (avoid if signs of infection are present) Over-the-counter oral antihistamines may help with bothersome itching Keep the area clean and dry Consult your healthcare provider for persistent or worsening reactions General Skin Care Recommendations during Zepbound treatment include: Maintain good skin hydration with fragrance-free moisturizers Avoid harsh soaps or skin products that may cause irritation Protect skin from excessive sun exposure Stay well-hydrated by drinking adequate fluids Report any new skin products or medications to your healthcare provider If recurrent or bothersome injection site reactions occur despite proper technique, discuss alternative injection sites or additional management strategies with your healthcare provider

Compounded Medications: Compounded tirzepatide is prepared by licensed pharmacists in regulated compounding pharmacies
Phase II clinical trials have observed their mechanism of action
GSH acts as a cofactor in the system of methylglyoxal elimination, which consists of two enzymes called glyoxalases (Yadav et al., 2008